Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgerie…
An institutional-grade, numbers-driven thesis on SYK — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates Stryker Corporation (SYK) 63/100 with a 12-month base-case forecast of $382.61 — +12.9% versus the current price of $339.03. Stryker Corporation trades at $339.03 in the Healthcare sector, with a market capitalisation of $129.97B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for SYK is $382.61, implying +12.9% versus the current price. The model's 12-month scenario range runs from $318.66 (bear) to $415.49 (bull), with a base case of $351.46.
On the fundamentals, Stryker shows a P/E of 34.8, trailing revenue of $25.12B, revenue growth of +11.2% YoY, a dividend yield of 1.03%. This page also tracks SYK's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
SYK currently carries a TradersQuant composite score of 63/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $382.61 implies +12.9% from $339.03. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for SYK is $382.61, about +12.9% versus the latest price of $339.03. Consensus is based on 51 analysts.
TradersQuant's 12-month model forecast for SYK is a base case of $351.46, ranging from $318.66 (bear) to $415.49 (bull), an expected return of +3.7%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for SYK over the next 12 months is $351.46 in the base case (bear $318.66, bull $415.49), versus today's price of $339.03. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for SYK — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates SYK's fair value at $382.61, implying +12.9% of expected upside versus the current price.
Yes — Stryker pays a dividend yielding 1.03% (about $3.48 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
